Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrasentan in Type 2 Diabetic Nephropathy
NCT00920764Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atrasentan in diabetic nephropathy (DN), sponsored by AbbVie Inc.. Started Jun 2009; status: completed.
02
Drugs
atrasentan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00920764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920764.